What's New on the FDA Drugs Site
June 16, 2015
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Manual of Policies and Procedures (MAPP) 4631.4 Monitoring and De-obligating Undelivered Orders (UDOs) (PDF - 82KB)
- FDA alerts health care providers, researchers and patients not to use certain products from ScienceLab.com
- FDA Drug Safety Communication: FDA determines 2013 labeling adequate to manage risk of retinal abnormalities, potential vision loss, and skin discoloration with anti-seizure drug Potiga (ezogabine); requires additional study
- FDA Drug Shortages
- Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection (Updated - Currently in Shortage)
- Calcium Gluconate Injection (Updated - Currently in Shortage)
- Cefotetan Disodium Injection (Updated - Currently in Shortage)
- Fomepizole Injection (Updated - Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (New - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Magnesium Sulfate Injection (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Naming of Drug Products Containing Salt Drug Substances Guidance for Industry (PDF - 210KB)
- National Drug Code Directory
No hay comentarios:
Publicar un comentario